Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial
Authors
Keywords
Antibody-mediated rejection, Donor-specific antibody, Bortezomib, Kidney transplantation, Proteasome inhibition
Journal
Trials
Volume 15, Issue 1, Pages 107
Publisher
Springer Nature
Online
2014-04-03
DOI
10.1186/1745-6215-15-107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Banff 2011 Meeting Report: New Concepts in Antibody-Mediated Rejection
- (2012) M. Mengel et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Proteasome inhibitor-based therapy for antibody-mediated rejection
- (2012) R. Carlin Walsh et al. KIDNEY INTERNATIONAL
- IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up
- (2012) Heiko Billing et al. TRANSPLANT INTERNATIONAL
- Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
- (2011) M. D. Stegall et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prevention and treatment of alloantibody-mediated kidney transplant rejection
- (2011) Gregor Bartel et al. TRANSPLANT INTERNATIONAL
- Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal
- (2010) K. E. Lamb et al. AMERICAN JOURNAL OF TRANSPLANTATION
- De NovoDonor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure
- (2009) L. G. Hidalgo et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection
- (2009) C. Lefaucheur et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure
- (2009) G. Einecke et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Proteasome inhibition for antibody-mediated rejection
- (2009) Jason J Everly et al. Current Opinion in Organ Transplantation
- Review article: Luminex technology for HLA antibody detection in organ transplantation
- (2009) BRIAN D TAIT et al. NEPHROLOGY
- Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts
- (2009) Nils Lachmann et al. TRANSPLANTATION
- Dampening Ab responses using proteasome inhibitors followingin vivo B cell activation
- (2008) Paolo Cascio et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- Successful Treatment of Chronic Antibody-Mediated Rejection With IVIG and Rituximab in Pediatric Renal Transplant Recipients
- (2008) Heiko Billing et al. TRANSPLANTATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started